{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_guselkumab",
          "name": "Guselkumab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ixekizumab",
          "name": "Ixekizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tildrakizumab",
          "name": "Tildrakizumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 2
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_acitretin",
          "type": "Drug",
          "label": "Acitretin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_apremilast",
          "type": "Drug",
          "label": "Apremilast",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brodalumab",
          "type": "Drug",
          "label": "Brodalumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_etanercept",
          "type": "Drug",
          "label": "Etanercept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_guselkumab",
          "type": "Drug",
          "label": "Guselkumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ixekizumab",
          "type": "Drug",
          "label": "Ixekizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_secukinumab",
          "type": "Drug",
          "label": "Secukinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tildrakizumab",
          "type": "Drug",
          "label": "Tildrakizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "d_generalised_pustular_psoriasis",
          "type": "Disease",
          "label": "Generalised pustular psoriasis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_tnf_inhibition",
          "type": "Target",
          "label": "TNF Inhibition",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_il_17_pathway",
          "type": "Target",
          "label": "IL-17 Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "t_il_23_pathway",
          "type": "Target",
          "label": "IL-23 Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "p_psoriasis_pathway",
          "type": "Pathway",
          "label": "Psoriasis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_acitretin",
          "target": "t_psoriasismediators",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "已知作用于皮肤组织"
        },
        {
          "source": "drug_adalimumab",
          "target": "t_tnf_inhibition",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "TNF 抑制直接相关"
        },
        {
          "source": "drug_apremilast",
          "target": "t_il_17_pathway",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与 IL-17 途径调节关联"
        },
        {
          "source": "drug_brodalumab",
          "target": "t_il_17_pathway",
          "relation": "inhibits",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "针对 IL-17 的抑制作用"
        },
        {
          "source": "drug_etanercept",
          "target": "t_tnf_inhibition",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接抑制 TNF"
        },
        {
          "source": "drug_guselkumab",
          "target": "t_il_23_pathway",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "IL-23 抑制机制关联"
        },
        {
          "source": "drug_infliximab",
          "target": "t_tnf_inhibition",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "TNF 抑制剂"
        },
        {
          "source": "drug_ixekizumab",
          "target": "t_il_17_pathway",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "通过 IL-17 的抑制作用"
        },
        {
          "source": "drug_methotrexate",
          "target": "p_psoriasis_pathway",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与银屑病治疗常识一致"
        },
        {
          "source": "drug_secukinumab",
          "target": "t_il_17_pathway",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接抑制 IL-17"
        },
        {
          "source": "drug_tildrakizumab",
          "target": "t_il_23_pathway",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "IL-23 抑制有效性"
        },
        {
          "source": "drug_ustekinumab",
          "target": "t_il_23_pathway",
          "relation": "inhibits",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对 IL-23 的抑制机制"
        },
        {
          "source": "t_tnf_inhibition",
          "target": "p_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "通路参与关系"
        },
        {
          "source": "t_il_17_pathway",
          "target": "p_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "IL-17 在皮炎过程中的角色"
        },
        {
          "source": "t_il_23_pathway",
          "target": "p_psoriasis_pathway",
          "relation": "involved_in",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "皮肤相关路径参与"
        },
        {
          "source": "p_psoriasis_pathway",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "causes",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "病理学上已知关联"
        },
        {
          "source": "drug_acitretin",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_adalimumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_apremilast",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_brodalumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_etanercept",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_guselkumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_infliximab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_ixekizumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_methotrexate",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_secukinumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_tildrakizumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        },
        {
          "source": "drug_ustekinumab",
          "target": "d_generalised_pustular_psoriasis",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "直接支持适应症"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Acitretin 和其他候选药物通过多种机制可能影响广义脓疱型银屑病",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "通过 TNF、IL-17 和 IL-23 的抑制途径，多个药物可能共同影响广义脓疱型银屑病",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "上述药物能有效达到相关靶器官和组织"
    ],
    "uncertainties": [
      "各药物的长期效果及其相互作用有待后续研究验证"
    ],
    "next_focus_for_pi": [
      "考虑是否加入新的数据或临床研究以验证效果"
    ]
  }
}